Trial Profile
An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Raptiva (Efalizumab)in Combination With Narrow Band Phototherapy for the Treatment of Moderate to Severe Plaque Psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2014
Price :
$35
*
At a glance
- Drugs Efalizumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 24 Oct 2014 New trial record